Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Operating Leases (2022 - 2025)

Core Scientific's Operating Leases history spans 4 years, with the latest figure at $102.7 million for Q2 2025.

  • For Q2 2025, Operating Leases changed N/A year-over-year to $102.7 million; the TTM value through Jun 2025 reached $102.7 million, changed N/A, while the annual FY2024 figure was $97.8 million, 6371.1% up from the prior year.
  • Operating Leases for Q2 2025 was $102.7 million at Core Scientific, up from $95.0 million in the prior quarter.
  • Across five years, Operating Leases topped out at $102.7 million in Q2 2025 and bottomed at $720000.0 in Q4 2022.
  • The 4-year median for Operating Leases is $69.0 million (2024), against an average of $52.5 million.
  • The largest annual shift saw Operating Leases soared 6371.1% in 2024 before it surged 37.57% in 2025.
  • A 4-year view of Operating Leases shows it stood at $720000.0 in 2022, then surged by 110.0% to $1.5 million in 2023, then skyrocketed by 6371.1% to $97.8 million in 2024, then grew by 4.93% to $102.7 million in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Operating Leases are $102.7 million (Q2 2025), $95.0 million (Q1 2025), and $97.8 million (Q4 2024).